Exane BNP Paribas assumed coverage on shares of Visteon (NASDAQ:VC – Get Rating) in a research note issued to investors on Monday, The Fly reports. The firm set a “neutral” rating and a $99.00 price target on the stock. Exane BNP Paribas’ target price would indicate a potential downside of 2.20% from the stock’s current […]
Visteon (NASDAQ:VC – Get Rating) had its price objective decreased by Barclays from $145.00 to $140.00 in a research note issued to investors on Thursday morning, The Fly reports. Barclays currently has an overweight rating on the stock. VC has been the subject of a number of other reports. Zacks Investment Research lowered Visteon from […]
Analysts forecast that Visteon Co. (NASDAQ:VC – Get Rating) will announce sales of $730.19 million for the current fiscal quarter, Zacks Investment Research reports. Five analysts have provided estimates for Visteon’s earnings, with estimates ranging from $691.00 million to $775.76 million. Visteon reported sales of $746.00 million in the same quarter last year, which would […]
Brokerages forecast that Visteon Co. (NASDAQ:VC – Get Rating) will announce $0.67 earnings per share (EPS) for the current fiscal quarter, according to Zacks. Four analysts have issued estimates for Visteon’s earnings, with estimates ranging from $0.04 to $0.88. Visteon reported earnings of $0.56 per share in the same quarter last year, which suggests a […]
Kirr Marbach & Co. LLC IN cut its holdings in Visteon Co. (NASDAQ:VC – Get Rating) by 0.6% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 71,489 shares of the company’s stock after selling 467 shares during the period. Visteon accounts for about 2.1% of Kirr […]